[8-K] Aveanna Healthcare Holdings, Inc. Reports Material Event
Aveanna Healthcare Holdings Inc. furnished an 8-K to announce it issued a press release with preliminary results for the three-month period ended September 27, 2025. The press release, dated October 21, 2025, is included as Exhibit 99.1.
The company states the information under Item 2.02 is “furnished” and not “filed” under the Exchange Act, and will only be incorporated by reference into other filings if specifically stated.
Aveanna Healthcare Holdings Inc. ha presentato un 8-K per annunciare che è stato emesso un comunicato stampa con i risultati preliminari per il periodo trimestrale chiuso il 27 settembre 2025. Il comunicato stampa, datato 21 ottobre 2025, è incluso come Allegato 99.1.
L'azienda afferma che le informazioni contenute nella voce 2.02 sono “fornite” e non “depositate” ai sensi della Exchange Act, e saranno incorporate a riferimento in altri depositi solo se esplicitamente specificato.
Aveanna Healthcare Holdings Inc. presentó un 8-K para anunciar que emitió un comunicado de prensa con resultados preliminares del periodo de tres meses terminado el 27 de septiembre de 2025. El comunicado, con fecha del 21 de octubre de 2025, se incluye como el Anexo 99.1.
La empresa indica que la información bajo el Item 2.02 es “proporcionada” y no “presentada” conforme a la Exchange Act, y solo se incorporará por referencia a otros archivos si se indica específicamente.
Aveanna Healthcare Holdings Inc. 는 2025년 9월 27일에 종료된 3개월 기간의 예비 결과를 발표하는 보도자료를 발표했다는 내용을 알리기 위해 8-K 를 제출했다. 이 보도자료는 2025년 10월 21일자로 작성되었으며 Exhibit 99.1 로 포함되어 있다.
회사는 Item 2.02 의 정보가 Exchange Act에 따라 '제출된' 것이 아니라 '제공된' 것이며, 다른 제출에 참조로 포함될 경우에만 명시적으로 명시될 때에만 포함된다고 밝히고 있다.
Aveanna Healthcare Holdings Inc. a déposé un 8-K pour annoncer qu'il a publié un communiqué de presse présentant des résultats préliminaires pour la période trimestrielle se terminant le 27 septembre 2025. Le communiqué, daté du 21 octobre 2025, est inclus en tant qu Exhibit 99.1.
La société indique que les informations contenues à l'item 2.02 sont « fournies » et non « déposées » en vertu de la Securities Exchange Act, et ne seront intégrées par référence dans d'autres dépôts que si cela est expressément indiqué.
Aveanna Healthcare Holdings Inc. hat ein 8-K eingereicht, um bekannt zu geben, dass eine Pressemitteilung mit vorläufigen Ergebnissen für den Dreimonatszeitraum beendet am 27. September 2025 veröffentlicht wurde. Die Pressemitteilung, datiert auf den 21. Oktober 2025, ist als Exhibit 99.1 enthalten.
Das Unternehmen gibt an, dass die Informationen unter Position 2.02 als „bereitgestellt“ und nicht als „eingereicht“ gemäß dem Exchange Act gelten und nur in anderen Einreichungen referenziert werden, wenn dies ausdrücklich angegeben wird.
Aveanna Healthcare Holdings Inc. قدمت نموذج 8-K للإعلان عن إصدارها بياناً صحفياً بنتائج أولية لفترة الثلاثة أشهر المنتهية في 27 سبتمبر 2025. البيان الصحفي، المؤرخ 21 أكتوبر 2025، مُدرَج كمعروض 99.1.
تذكر الشركة أن المعلومات الواردة في البند 2.02 هي "مقدمة" وليست "مسجلة" بموجب قانون التبادل، ولن يتم إدراجها إلا بالرجوع إليها في ملفات أخرى إذا ورد ذكر ذلك صراحة.
Aveanna Healthcare Holdings Inc. 发布了 8-K，宣布发布了一份新闻稿，其中包含截至 2025 年 9 月 27 日结束的三个月期的初步业绩。该新闻稿日期为 2025 年 10 月 21 日，作为 Exhibit 99.1 包含在内。
公司表示，第 2.02 项的信息是“提供”而非“备案”，只有在明确声明时才会通过引用并入其他文件。
- None.
- None.
Aveanna Healthcare Holdings Inc. ha presentato un 8-K per annunciare che è stato emesso un comunicato stampa con i risultati preliminari per il periodo trimestrale chiuso il 27 settembre 2025. Il comunicato stampa, datato 21 ottobre 2025, è incluso come Allegato 99.1.
L'azienda afferma che le informazioni contenute nella voce 2.02 sono “fornite” e non “depositate” ai sensi della Exchange Act, e saranno incorporate a riferimento in altri depositi solo se esplicitamente specificato.
Aveanna Healthcare Holdings Inc. presentó un 8-K para anunciar que emitió un comunicado de prensa con resultados preliminares del periodo de tres meses terminado el 27 de septiembre de 2025. El comunicado, con fecha del 21 de octubre de 2025, se incluye como el Anexo 99.1.
La empresa indica que la información bajo el Item 2.02 es “proporcionada” y no “presentada” conforme a la Exchange Act, y solo se incorporará por referencia a otros archivos si se indica específicamente.
Aveanna Healthcare Holdings Inc. 는 2025년 9월 27일에 종료된 3개월 기간의 예비 결과를 발표하는 보도자료를 발표했다는 내용을 알리기 위해 8-K 를 제출했다. 이 보도자료는 2025년 10월 21일자로 작성되었으며 Exhibit 99.1 로 포함되어 있다.
회사는 Item 2.02 의 정보가 Exchange Act에 따라 '제출된' 것이 아니라 '제공된' 것이며, 다른 제출에 참조로 포함될 경우에만 명시적으로 명시될 때에만 포함된다고 밝히고 있다.
Aveanna Healthcare Holdings Inc. a déposé un 8-K pour annoncer qu'il a publié un communiqué de presse présentant des résultats préliminaires pour la période trimestrielle se terminant le 27 septembre 2025. Le communiqué, daté du 21 octobre 2025, est inclus en tant qu Exhibit 99.1.
La société indique que les informations contenues à l'item 2.02 sont « fournies » et non « déposées » en vertu de la Securities Exchange Act, et ne seront intégrées par référence dans d'autres dépôts que si cela est expressément indiqué.
Aveanna Healthcare Holdings Inc. hat ein 8-K eingereicht, um bekannt zu geben, dass eine Pressemitteilung mit vorläufigen Ergebnissen für den Dreimonatszeitraum beendet am 27. September 2025 veröffentlicht wurde. Die Pressemitteilung, datiert auf den 21. Oktober 2025, ist als Exhibit 99.1 enthalten.
Das Unternehmen gibt an, dass die Informationen unter Position 2.02 als „bereitgestellt“ und nicht als „eingereicht“ gemäß dem Exchange Act gelten und nur in anderen Einreichungen referenziert werden, wenn dies ausdrücklich angegeben wird.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): |
(Exact name of Registrant as Specified in Its Charter)
(State or Other Jurisdiction |
(Commission File Number) |
(IRS Employer |
||
|
|
|
|
|
|
||||
|
||||
(Address of Principal Executive Offices) |
|
(Zip Code) |
||
Registrant’s Telephone Number, Including Area Code: |
|
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Securities registered pursuant to Section 12(b) of the Act:
|
|
Trading |
|
|
|
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and Financial Information.
On October 21, 2025, Aveanna Healthcare Holdings Inc. issued a press release reporting certain preliminary financial results for the three-month period ended September 27, 2025. A copy of the press release is attached hereto as Exhibit 99.1 and incorporated by reference herein.
The information contained in this Item 2.02, including in Exhibit 99.1 attached hereto, is “furnished” and not “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section. Such information shall not be incorporated by reference in another filing under the Exchange Act or the Securities Act of 1933, as amended, except to the extent such other filing specifically incorporates such information by reference.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
Exhibit Number |
|
Description |
99.1 |
|
Press release dated October 21, 2025 |
104 |
|
Cover Page Interactive Data File (embedded within the Inline XBRL document) |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
AVEANNA HEALTHCARE HOLDINGS INC. |
|
|
|
|
Date: |
October 21, 2025 |
By: |
/s/ Matthew Buckhalter |
|
|
|
Matthew Buckhalter |
